LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 8 of total 8

Search options

  1. Article ; Online: Similar immune mechanisms control experimental airway eosinophilia elicited by different allergens and treatment protocols.

    Hyde, Evelyn J / Wakelin, Kirsty A / Daniels, Naomi J / Ghosh, Sayani / Ronchese, Franca

    BMC immunology

    2019  Volume 20, Issue 1, Page(s) 18

    Abstract: Background: Mouse models have been extremely valuable in identifying the fundamental mechanisms of airway inflammation that underlie human allergic asthma. Several models are commonly used, employing different methods and routes of sensitisation, and ... ...

    Abstract Background: Mouse models have been extremely valuable in identifying the fundamental mechanisms of airway inflammation that underlie human allergic asthma. Several models are commonly used, employing different methods and routes of sensitisation, and allergens of varying clinical relevance. Although all models elicit similar hallmarks of allergic airway inflammation, including airway eosinophilia, goblet cell hyperplasia and cellular infiltration in lung, it is not established whether they do so by involving the same mechanisms.
    Results: We compared the impact of inactivation of various innate or adaptive immune genes, as well as sex, in different models of allergic airway inflammation in mice of C57BL/6 background. Chicken ovalbumin (OVA) and house dust mite (HDM) were used as allergens in settings of single or multiple intranasal (i.n.) challenges, after sensitisation in adjuvant or in adjuvant-free conditions. Eosinophil numbers in the broncho-alveolar lavage and lung histopathology were assessed in each model. We found that Major Histocompatibility Complex Class II (MHCII) deficiency and lack of conventional CD4+ T cells had the most profound effect, essentially ablating airway eosinophilia and goblet cell hyperplasia in all models. In contrast, Thymic stromal lymphopoietin receptor (TSLPR) deficiency greatly reduced eosinophilia but had a variable effect on goblet cells. CD1d deficiency and lack of Natural Killer T (NKT) cells moderately impaired inflammation in OVA models but not HDM, whereas sex affected the response to HDM but not OVA. Lastly, defective Toll-like receptor (TLR)4 expression had only a relatively modest overall impact on inflammation.
    Conclusion: All the models studied were comparably dependent on adaptive CD4+ T cell responses and TSLP. In contrast, sex, NKT cells and TLR4 appeared to play subtler and more variable roles that were dependent on the type of allergen and mode of immunization and challenge. These results are consistent with clinical data suggesting a key role of CD4+ T cells and TSLP in patients with allergic asthma.
    MeSH term(s) Adaptive Immunity/genetics ; Adjuvants, Immunologic ; Allergens/immunology ; Animals ; Antigens, Dermatophagoides/immunology ; Eosinophilia/immunology ; Female ; Goblet Cells/pathology ; Humans ; Immunity, Innate/genetics ; Lung/immunology ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Models, Animal ; Ovalbumin/immunology ; Respiratory Hypersensitivity/immunology
    Chemical Substances Adjuvants, Immunologic ; Allergens ; Antigens, Dermatophagoides ; Ovalbumin (9006-59-1)
    Language English
    Publishing date 2019-06-04
    Publishing country England
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1471-2172
    ISSN (online) 1471-2172
    DOI 10.1186/s12865-019-0295-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Clec9A

    Gilfillan, Connie B / Kuhn, Sabine / Baey, Camille / Hyde, Evelyn J / Yang, Jianping / Ruedl, Christiane / Ronchese, Franca

    Journal of immunology (Baltimore, Md. : 1950)

    2018  Volume 200, Issue 8, Page(s) 2978–2986

    Abstract: In the steady state, tumors harbor several populations of dendritic cells (DCs) and myeloid cells that are key regulators of the intratumoral immune environment. Among these cells, migratory ... ...

    Abstract In the steady state, tumors harbor several populations of dendritic cells (DCs) and myeloid cells that are key regulators of the intratumoral immune environment. Among these cells, migratory CD103
    MeSH term(s) Animals ; CD8-Positive T-Lymphocytes/immunology ; Cross-Priming/immunology ; Dendritic Cells/immunology ; Female ; Immunotherapy/methods ; Interferon Inducers/immunology ; Lectins, C-Type/immunology ; Mammary Neoplasms, Experimental/immunology ; Melanoma, Experimental/immunology ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Poly I-C/immunology ; Receptors, Immunologic/immunology
    Chemical Substances Clec9a protein, mouse ; Interferon Inducers ; Lectins, C-Type ; Receptors, Immunologic ; Poly I-C (O84C90HH2L)
    Language English
    Publishing date 2018-03-05
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 3056-9
    ISSN 1550-6606 ; 0022-1767 ; 1048-3233 ; 1047-7381
    ISSN (online) 1550-6606
    ISSN 0022-1767 ; 1048-3233 ; 1047-7381
    DOI 10.4049/jimmunol.1701593
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Dermal IRF4+ dendritic cells and monocytes license CD4+ T helper cells to distinct cytokine profiles.

    Hilligan, Kerry L / Tang, Shiau-Choot / Hyde, Evelyn J / Roussel, Elsa / Mayer, Johannes U / Yang, Jianping / Wakelin, Kirsty A / Schmidt, Alfonso J / Connor, Lisa M / Sher, Alan / MacDonald, Andrew S / Ronchese, Franca

    Nature communications

    2020  Volume 11, Issue 1, Page(s) 5637

    Abstract: Antigen (Ag)-presenting cells (APC) instruct CD4+ helper T (Th) cell responses, but it is unclear whether different APC subsets contribute uniquely in determining Th differentiation in pathogen-specific settings. Here, we use skin-relevant, fluorescently- ...

    Abstract Antigen (Ag)-presenting cells (APC) instruct CD4+ helper T (Th) cell responses, but it is unclear whether different APC subsets contribute uniquely in determining Th differentiation in pathogen-specific settings. Here, we use skin-relevant, fluorescently-labeled bacterial, helminth or fungal pathogens to track and characterize the APC populations that drive Th responses in vivo. All pathogens are taken up by a population of IRF4+ dermal migratory dendritic cells (migDC2) that similarly upregulate surface co-stimulatory molecules but express pathogen-specific cytokine and chemokine transcripts. Depletion of migDC2 reduces the amount of Ag in lymph node and the development of IFNγ, IL-4 and IL-17A responses without gain of other cytokine responses. Ag+ monocytes are an essential source of IL-12 for both innate and adaptive IFNγ production, and inhibit follicular Th cell development. Our results thus suggest that Th cell differentiation does not require specialized APC subsets, but is driven by inducible and pathogen-specific transcriptional programs in Ag+ migDC2 and monocytes.
    MeSH term(s) Animals ; Antigen-Presenting Cells/immunology ; Cell Differentiation ; Dendritic Cells/immunology ; Female ; Interferon Regulatory Factors/genetics ; Interferon Regulatory Factors/immunology ; Interferon-gamma/genetics ; Interferon-gamma/immunology ; Interleukin-17/genetics ; Interleukin-17/immunology ; Interleukin-4/genetics ; Interleukin-4/immunology ; Lymphocyte Activation ; Male ; Mice ; Mice, Inbred C57BL ; Monocytes/cytology ; Monocytes/immunology ; Skin/immunology ; T-Lymphocytes, Helper-Inducer/cytology ; T-Lymphocytes, Helper-Inducer/immunology
    Chemical Substances Interferon Regulatory Factors ; Interleukin-17 ; interferon regulatory factor-4 ; Interleukin-4 (207137-56-2) ; Interferon-gamma (82115-62-6)
    Language English
    Publishing date 2020-11-06
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-020-19463-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: IL-1βR-dependent priming of antitumor CD4

    Kuhn, Sabine / Yang, Jianping / Hyde, Evelyn J / Harper, Jacquie L / Kirman, Joanna R / Ronchese, Franca

    Oncoimmunology

    2015  Volume 4, Issue 10, Page(s) e1042199

    Abstract: Local immune-activating therapies seek to improve the presentation of tumor antigen, thereby promoting the activation of antitumor ... ...

    Abstract Local immune-activating therapies seek to improve the presentation of tumor antigen, thereby promoting the activation of antitumor CD8
    Language English
    Publishing date 2015-06-26
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2645309-5
    ISSN 2162-402X ; 2162-4011
    ISSN (online) 2162-402X
    ISSN 2162-4011
    DOI 10.1080/2162402X.2015.1042199
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Author Correction: Homeostatic IL-13 in healthy skin directs dendritic cell differentiation to promote T

    Mayer, Johannes U / Hilligan, Kerry L / Chandler, Jodie S / Eccles, David A / Old, Samuel I / Domingues, Rita G / Yang, Jianping / Webb, Greta R / Munoz-Erazo, Luis / Hyde, Evelyn J / Wakelin, Kirsty A / Tang, Shiau-Choot / Chappell, Sally C / von Daake, Sventja / Brombacher, Frank / Mackay, Charles R / Sher, Alan / Tussiwand, Roxane / Connor, Lisa M /
    Gallego-Ortega, David / Jankovic, Dragana / Le Gros, Graham / Hepworth, Matthew R / Lamiable, Olivier / Ronchese, Franca

    Nature immunology

    2022  Volume 23, Issue 6, Page(s) 985

    Language English
    Publishing date 2022-04-13
    Publishing country United States
    Document type Published Erratum
    ZDB-ID 2016987-5
    ISSN 1529-2916 ; 1529-2908
    ISSN (online) 1529-2916
    ISSN 1529-2908
    DOI 10.1038/s41590-022-01203-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Induction of T cell responses and recruitment of an inflammatory dendritic cell subset following tumor immunotherapy with Mycobacterium smegmatis.

    Rich, Fenella J / Kuhn, Sabine / Hyde, Evelyn J / Harper, Jacquie L / Ronchese, Franca / Kirman, Joanna R

    Cancer immunology, immunotherapy : CII

    2012  Volume 61, Issue 12, Page(s) 2333–2342

    Abstract: Mycobacteria and their cell wall components have been used with varying degrees of success to treat tumors, and Mycobacterium bovis BCG remains in use as a standard treatment for superficial bladder cancer. Mycobacterial immunotherapy is very effective ... ...

    Abstract Mycobacteria and their cell wall components have been used with varying degrees of success to treat tumors, and Mycobacterium bovis BCG remains in use as a standard treatment for superficial bladder cancer. Mycobacterial immunotherapy is very effective in eliciting local immune responses against solid tumors when administered topically; however, its effectiveness in eliciting adaptive immune responses has been variable. Using a subcutaneous mouse thymoma model, we investigated whether immunotherapy with Mycobacterium smegmatis, a fast-growing mycobacterium of low pathogenicity, induces a systemic adaptive immune response. We found that M. smegmatis delivered adjacent to the tumor site elicited a systemic anti-tumor immune response that was primarily mediated by CD8(+) T cells. Of note, we identified a CD11c(+)CD40(int)CD11b(hi)Gr-1(+) inflammatory DC population in the tumor-draining lymph nodes that was found only in mice treated with M. smegmatis. Our data suggest that, rather than rescuing the function of the DC already present in the tumor and/or tumor-draining lymph node, M. smegmatis treatment may promote anti-tumor immune responses by inducing the involvement of a new population of inflammatory cells with intact function.
    MeSH term(s) Adaptive Immunity/immunology ; Animals ; CD8-Positive T-Lymphocytes/immunology ; Dendritic Cells/immunology ; Immunotherapy/methods ; Inflammation/immunology ; Lymph Nodes/immunology ; Mice ; Mice, Inbred C57BL ; Mycobacterium smegmatis/immunology ; Thymoma/immunology ; Thymoma/therapy ; Thymus Neoplasms/immunology ; Thymus Neoplasms/therapy
    Language English
    Publishing date 2012-06-20
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 195342-4
    ISSN 1432-0851 ; 0340-7004
    ISSN (online) 1432-0851
    ISSN 0340-7004
    DOI 10.1007/s00262-012-1291-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Homeostatic IL-13 in healthy skin directs dendritic cell differentiation to promote T

    Mayer, Johannes U / Hilligan, Kerry L / Chandler, Jodie S / Eccles, David A / Old, Samuel I / Domingues, Rita G / Yang, Jianping / Webb, Greta R / Munoz-Erazo, Luis / Hyde, Evelyn J / Wakelin, Kirsty A / Tang, Shiau-Choot / Chappell, Sally C / von Daake, Sventja / Brombacher, Frank / Mackay, Charles R / Sher, Alan / Tussiwand, Roxane / Connor, Lisa M /
    Gallego-Ortega, David / Jankovic, Dragana / Le Gros, Graham / Hepworth, Matthew R / Lamiable, Olivier / Ronchese, Franca

    Nature immunology

    2021  Volume 22, Issue 12, Page(s) 1538–1550

    Abstract: The signals driving the adaptation of type 2 dendritic cells (DC2s) to diverse peripheral environments remain mostly undefined. We show that differentiation of ... ...

    Abstract The signals driving the adaptation of type 2 dendritic cells (DC2s) to diverse peripheral environments remain mostly undefined. We show that differentiation of CD11b
    MeSH term(s) Allergens/pharmacology ; Animals ; CD11b Antigen/genetics ; CD11b Antigen/metabolism ; Cell Communication ; Cell Differentiation ; Cells, Cultured ; Databases, Genetic ; Humans ; Interleukin-13/genetics ; Interleukin-13/metabolism ; Langerhans Cells/drug effects ; Langerhans Cells/immunology ; Langerhans Cells/metabolism ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Mice, Knockout ; Phenotype ; STAT6 Transcription Factor/genetics ; STAT6 Transcription Factor/metabolism ; Signal Transduction ; Skin/cytology ; Skin/drug effects ; Skin/immunology ; Skin/metabolism ; Th17 Cells/drug effects ; Th17 Cells/immunology ; Th17 Cells/metabolism ; Th2 Cells/drug effects ; Th2 Cells/immunology ; Th2 Cells/metabolism ; Transcriptome ; Mice
    Chemical Substances Allergens ; CD11b Antigen ; IL13 protein, human ; ITGAM protein, human ; Interleukin-13 ; Itgam protein, mouse ; STAT6 Transcription Factor ; STAT6 protein, human ; Stat6 protein, mouse
    Language English
    Publishing date 2021-11-18
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2016987-5
    ISSN 1529-2916 ; 1529-2908
    ISSN (online) 1529-2916
    ISSN 1529-2908
    DOI 10.1038/s41590-021-01067-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.

    Kuhn, Sabine / Hyde, Evelyn J / Yang, Jianping / Rich, Fenella J / Harper, Jacquie L / Kirman, Joanna R / Ronchese, Franca

    Journal of immunology (Baltimore, Md. : 1950)

    2013  Volume 191, Issue 4, Page(s) 1984–1992

    Abstract: Local treatment with selected TLR ligands or bacteria such as bacillus Calmette-Guérin increases antitumor immune responses and delays tumor growth. It is thought that these treatments may act by activating tumor-associated dendritic cells (DCs), thereby ...

    Abstract Local treatment with selected TLR ligands or bacteria such as bacillus Calmette-Guérin increases antitumor immune responses and delays tumor growth. It is thought that these treatments may act by activating tumor-associated dendritic cells (DCs), thereby supporting the induction of antitumor immune responses. However, common parameters of successful immune activation have not been identified. We used mouse models to compare treatments with different immune-activating agents for the ability to delay tumor growth, improve priming of tumor-specific T cells, and induce early cytokine production and DC activation. Treatment with polyinosinic-polycytidylic acid or a combination of monosodium urate crystals and Mycobacterium smegmatis was effective at delaying the growth of s.c. B16 melanomas, orthotopic 4T1 mammary carcinomas, and reducing 4T1 lung metastases. In contrast, LPS, monosodium urate crystals, or M. smegmatis alone had no activity. Effective treatments required both NK1.1(+) and CD8(+) cells, and resulted in increased T cell priming and the infiltration of NK cells and CD8(+) T cells in tumors. Unexpectedly, both effective and ineffective treatments increased DC numbers and the expression of costimulatory molecules in the tumor-draining lymph node. However, only effective treatments induced the rapid appearance of a population of monocyte-derived DCs in the draining lymph node, early release of IL-12p70 and IFN-γ, and low IL-10 in the serum. These results suggest that the activation of existing DC subsets is not sufficient for the induction of antitumor immune responses, whereas early induction of Th1 cytokines and monocyte-derived DCs are features of successful activation of antitumor immunity.
    MeSH term(s) Adaptive Immunity ; Adjuvants, Immunologic/therapeutic use ; Animals ; Biological Therapy ; CD8-Positive T-Lymphocytes/immunology ; Carcinoma/immunology ; Carcinoma/secondary ; Carcinoma/therapy ; Cell Count ; Cell Differentiation/drug effects ; Cytokines/biosynthesis ; Cytokines/genetics ; Dendritic Cells/immunology ; Escherichia coli/immunology ; Female ; Immunotherapy ; Immunotherapy, Adoptive ; Interferon-gamma/secretion ; Interleukin-10/blood ; Interleukin-12/secretion ; Killer Cells, Natural/immunology ; Lung Neoplasms/prevention & control ; Lung Neoplasms/secondary ; Lymph Nodes/pathology ; Lymphocytes, Tumor-Infiltrating/immunology ; Male ; Mammary Neoplasms, Experimental/immunology ; Mammary Neoplasms, Experimental/pathology ; Mammary Neoplasms, Experimental/therapy ; Melanoma, Experimental/immunology ; Melanoma, Experimental/secondary ; Melanoma, Experimental/therapy ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Mice, Transgenic ; Monocytes/drug effects ; Monocytes/immunology ; Mycobacterium smegmatis/immunology ; Ovalbumin/immunology ; Peptide Fragments/immunology ; Poly I-C/pharmacology ; Poly I-C/therapeutic use ; Radiation Chimera ; Receptors, Antigen, T-Cell/immunology ; T-Lymphocyte Subsets/immunology ; T-Lymphocyte Subsets/transplantation ; Th1 Cells/immunology ; Th1 Cells/metabolism ; Uric Acid/pharmacology ; Uric Acid/therapeutic use
    Chemical Substances Adjuvants, Immunologic ; Cytokines ; IL10 protein, mouse ; OVA-8 ; Peptide Fragments ; Receptors, Antigen, T-Cell ; Interleukin-10 (130068-27-8) ; Interleukin-12 (187348-17-0) ; Uric Acid (268B43MJ25) ; Interferon-gamma (82115-62-6) ; Ovalbumin (9006-59-1) ; Poly I-C (O84C90HH2L)
    Language English
    Publishing date 2013-08-15
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 3056-9
    ISSN 1550-6606 ; 0022-1767 ; 1048-3233 ; 1047-7381
    ISSN (online) 1550-6606
    ISSN 0022-1767 ; 1048-3233 ; 1047-7381
    DOI 10.4049/jimmunol.1301135
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top